2005
The urban built environment and overdose mortality in New York City neighborhoods
Hembree C, Galea S, Ahern J, Tracy M, Piper T, Miller J, Vlahov D, Tardiff K. The urban built environment and overdose mortality in New York City neighborhoods. Health & Place 2005, 11: 147-156. PMID: 15629682, DOI: 10.1016/j.healthplace.2004.02.005.Peer-Reviewed Original ResearchConceptsAccidental drug overdoseNew York City HousingMultilevel case-control studyNew York City OfficeNew York City neighborhoodsAccidental overdose deathsFatal drug overdoseCharacteristics of neighborhoodsCity housingDrug overdose mortalityCity neighborhoodsVacancy SurveyMayor's OfficeDifferent neighborhoodsCity OfficeNeighborhood-level variablesNeighborhoodInternal environmentNeighborhood differencesExternal environmentOfficeEnvironmentHousingDisinvestmentSocial resources
1998
Community Support for Needle Exchange Programs and Pharmacy Sale of Syringes: A Household Survey in Baltimore, Maryland
Keyl P, Gruskin L, Casano K, Montag H, Junge B, Vlahov D. Community Support for Needle Exchange Programs and Pharmacy Sale of Syringes: A Household Survey in Baltimore, Maryland. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s82-s88. PMID: 9663629, DOI: 10.1097/00042560-199802001-00015.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAttitude to HealthBaltimoreEducational StatusFamily CharacteristicsFemaleHealth Knowledge, Attitudes, PracticeHealth SurveysHIV InfectionsHumansIncomeInterviews as TopicMaleMiddle AgedMultivariate AnalysisNeedle-Exchange ProgramsPharmaciesRegression AnalysisSurveys and QuestionnairesSyringesConceptsNeedle exchange programsInjection drug useInjection drug usersDrug usersMultivariate logistic regressionContiguous census tractsHIV incidenceNeedle exchangeDrug useEligible respondentsLogistic regressionExchange programsPharmacy salesCensus populationRandom sampleCensus tractsHousehold interviewsCommunity supportCommunity attitudesBaltimoreHousehold surveyIncidenceRespondentsTractNeedle
1991
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal Of Public Health 1991, 81: 1285-90. PMID: 1928527, PMCID: PMC1405342, DOI: 10.2105/ajph.81.10.1285.Peer-Reviewed Original ResearchConceptsIntravenous drug usersCD4 cell countDrug usersHealth servicesHIV serostatusClinical symptomsHIV-seropositive intravenous drug usersHealth insuranceCell countAsymptomatic HIV-1 infectionSeropositive intravenous drug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive drug usersOngoing natural history studyLow CD4 countHIV-1 seropositiveImmunodeficiency virus infectionHIV-1 serostatusHealth care utilizationHIV-1 infectionHIV-positive serostatusNatural history studiesHealth care servicesCD4 countMore HIV